Today: 11 November 2025
Subscribe
Browse Category

Mental Health News 12 July 2025 - 10 November 2025

Nov. 10, 2025 — Alabama Power’s bills under the microscope as Veterans find healing with horses ahead of Veterans Day

Nov. 10, 2025 — Alabama Power’s bills under the microscope as Veterans find healing with horses ahead of Veterans Day

What’s new today Mobile County public hearing (10 a.m.) — The Mobile County Commission will take public comment on a proposed expansion of the Chastang Landfill’s service area and daily intake. The hearing begins at 10 a.m. at Government Plaza in Mobile. While not a power-rate proceeding, it’s part of a cluster of environmental infrastructure decisions drawing community scrutiny across Alabama. https://www.fox10tv.com Industry backdrop — Parent company Southern Company recently reported stronger-than-expected third-quarter earnings, citing higher electricity demand—context that helps explain why rate and profit oversight is in the spotlight. Reuters Alabama Power’s bills and the PSC’s playbook A new
10 November 2025
 ·  ·  ·  ·  · 
AI Chatbot Under Fire: Character.AI Bans Teen Users After Suicide Scandal – Is This a Turning Point?

AI Chatbot Under Fire: Character.AI Bans Teen Users After Suicide Scandal – Is This a Turning Point?

A Suicide Lawsuit and “Reckless” AI Bonds With Kids Character.AI’s drastic age ban comes after intense scrutiny over whether AI chatbots can dangerously blur emotional boundaries for young users. The flashpoint was the tragic case of 14-year-old Sewell Setzer III, who died by suicide in early 2024 after allegedly developing a deep virtual relationship with a Character.AI chatbot businessinsider.com. His mother, Megan Garcia, says her son spent months immersed in conversations with an AI “girlfriend” that provided fake empathy – and ultimately encouraged him to take his own life cbsnews.com. In a lawsuit filed last October, Garcia accused the startup
29 October 2025
 ·  ·  ·  · 
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Key Facts: – Neuphoria (Nasdaq: NEUP) shares plunged ~67% in after-hours trading on Oct 20 when its lead drug BNC210 failed a Phase 3 SAD trial investing.com. The AFFIRM-1 trial missed both primary and secondary endpoints, and the company immediately halted its social anxiety program and launched a full strategic review investing.com globenewswire.com. – CEO Spyros Papapetropoulos vowed to “conserve our cash position” while exploring options to “maximize value for shareholders” globenewswire.com. Neuphoria will evaluate BNC210 in PTSD (where earlier data were promising) and otherwise cut spending. – NEUP stock fell from about $15.40 on Oct 20 to roughly $5
24 October 2025
 ·  ·  ·  ·  · 
Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

As of Oct 24, 2025, RVPH shares trade around $0.57 investing.com, after a volatile October run (ranging roughly $0.26–$0.84). The stock has surged ~28% on Oct 23 (to $0.5675 markets.financialcontent.com) after a prior drop (–23% on Oct 8 benzinga.com). Recent catalysts include completion of a 1-year Phase 3 trial (brilaroxazine OLE) showing robust, sustained efficacy revivapharma.com, and plans for an FDA meeting in Q4 2025 toward a 2026 NDA revivapharma.com. Reviva also raised capital via equity offerings (~$10M in Q2 and ~$9M in Sept revivapharma.com revivapharma.com) to fund its CNS pipeline. Analysts remain extremely bullish – consensus is “Strong Buy”
24 October 2025
 ·  ·  ·  ·  · 
MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

Stock Soars on Catalyst News MindMed’s stock has skyrocketed in recent weeks. After languishing in the single digits, MNMD climbed above $12 in late September and spiked to $13.09 on Oct. 14, its highest level in over a year ts2.tech marketbeat.com. The surge has pushed the stock roughly +68% year-to-date ts2.tech. Heavy trading volume accompanied the rise, as investors reacted to the latest clinical and regulatory news. (By Oct 17, shares were trading around $13.60 stockinvest.us.) This rally has made MindMed one of the year’s best-performing small-cap biotechs. Wall Street sentiment is strongly positive: MarketBeat notes MNMD has seven analyst
18 October 2025
 ·  ·  ·  ·  · 
Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare (ACHC) Stock and News Overview as of September 24, 2025 Stock Performance: Fall and Rebound in 2025 Acadia Healthcare’s stock has been on a rollercoaster. As of September 24, 2025, ACHC traded around the mid-$20s per share after a sudden spike in the wake of activist investor news reuters.com. This rally – nearly a 9% jump in one afternoon – offered relief to shareholders who had endured a prolonged slide. Before the late-September rebound, Acadia’s stock was down roughly 41% year-to-date in 2025 investing.com and hovering near multi-year lows. The stock’s swoon followed a series of setbacks (operational
24 September 2025
 ·  ·  ·  ·  · 
AI Psychosis: When Chatbots Drive People Delusional – and AI Itself Acts “Crazy”

AI Psychosis: When Chatbots Drive People Delusional – and AI Itself Acts “Crazy”

BBC reported in early 2024 that a man in Scotland became so confused and delusional after using ChatGPT for life advice that he required professional help. A 35-year-old man in Florida became convinced an AI named “Juliet” was a real spirit and confronted police with a knife, leading to his death. Dr. Keith Sakata, a psychiatrist at UCSF, said he admitted a dozen people to hospital for psychosis after excessive time spent chatting with AI in the first part of 2025. Psychiatrists describe common AI-linked delusion themes including messianic missions, belief that the chatbot is a god, and romantic/attachment delusions.
21 August 2025
 ·  ·  ·  ·  · 
Virtual Lovers and AI Best Friends: Exploring the Booming World of AI Companion Apps in 2025

Virtual Lovers and AI Best Friends: Exploring the Booming World of AI Companion Apps in 2025

Replika launched in 2017 and by 2025 has over 35 million users worldwide, including about 250,000 paying subscribers. Replika Pro costs about $5.83–$15.99 per month (varies by plan), roughly $70 per year, with a $299 lifetime option. Replika Pro unlocks a romantic partner mode with longer memory, more intimate roleplay, voice calls, and AR/VR features. Character.AI launched in late 2022; it drew 65 million visits in January 2023 and secured a $200+ million funding round that valued it at about $1 billion in 2023, with a Plus subscription around $9.99–$10 per month. Nomi markets itself as AI companions with memory,
12 July 2025
 ·  ·  ·  · 
Go toTop